| Dr Kimberly Goergiann Bray, OD | |
|
3801 S Us Highway 41 Ste A-1, Terre Haute, IN 47802-4107 | |
| (812) 232-7461 | |
| Not Available |
| Full Name | Dr Kimberly Goergiann Bray |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 3801 S Us Highway 41 Ste A-1, Terre Haute, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073630950 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 18003333B (Indiana) | Primary |
| Provider Name | Ky Doctors Of Optometry Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235143538 PECOS PAC ID: 0941108732 Enrollment ID: O20050126000959 |
News Archive
Merck Serono, a division of Merck KGaA, and EPFL (Ecole Polytechnique Fédérale de Lausanne), one of the two Swiss Federal Institutes of Technology, announced the signing of a research collaboration agreement in the areas of Neuroscience, Oncology and Drug Delivery. Under this agreement, three Merck Serono-endowed Chairs will be created at EPFL: in neurodegenerative diseases, such as Alzheimer's and Parkinson's; in cancer, in the framework of the Swiss Institute for Experimental Cancer Research (ISREC); and in innovative drug delivery technologies, for instance nanoparticle vaccines.
CombinatoRx, Incorporated today announced that its abstract entitled, "CRx-102 (Prednisolone/Dipyridamole Combination) Enhances Glucocorticoid (GC) Efficacy and Reduces Adverse Effects in OA Therapy: 3-12 Month Results", has been accepted for oral presentation at the American College of Rheumatology (ACR) 2009 Annual Meeting in Philadelphia on October 20, 2009.
Ambit Biosciences Corporation, a recognized global leader in kinase drug discovery and development, announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
People in addiction recovery and their loved ones understand all too well how addiction can damage their relationships. But recovery programs do not always give people the relationship skills needed to address those issues.
› Verified 2 days ago
| Provider Name | First Impressions Optometric Associates, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1083366363 PECOS PAC ID: 6800281825 Enrollment ID: O20220309002226 |
News Archive
Merck Serono, a division of Merck KGaA, and EPFL (Ecole Polytechnique Fédérale de Lausanne), one of the two Swiss Federal Institutes of Technology, announced the signing of a research collaboration agreement in the areas of Neuroscience, Oncology and Drug Delivery. Under this agreement, three Merck Serono-endowed Chairs will be created at EPFL: in neurodegenerative diseases, such as Alzheimer's and Parkinson's; in cancer, in the framework of the Swiss Institute for Experimental Cancer Research (ISREC); and in innovative drug delivery technologies, for instance nanoparticle vaccines.
CombinatoRx, Incorporated today announced that its abstract entitled, "CRx-102 (Prednisolone/Dipyridamole Combination) Enhances Glucocorticoid (GC) Efficacy and Reduces Adverse Effects in OA Therapy: 3-12 Month Results", has been accepted for oral presentation at the American College of Rheumatology (ACR) 2009 Annual Meeting in Philadelphia on October 20, 2009.
Ambit Biosciences Corporation, a recognized global leader in kinase drug discovery and development, announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
People in addiction recovery and their loved ones understand all too well how addiction can damage their relationships. But recovery programs do not always give people the relationship skills needed to address those issues.
› Verified 2 days ago
| Provider Name | Irefract Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1679166193 PECOS PAC ID: 9739598343 Enrollment ID: O20230105002545 |
News Archive
Merck Serono, a division of Merck KGaA, and EPFL (Ecole Polytechnique Fédérale de Lausanne), one of the two Swiss Federal Institutes of Technology, announced the signing of a research collaboration agreement in the areas of Neuroscience, Oncology and Drug Delivery. Under this agreement, three Merck Serono-endowed Chairs will be created at EPFL: in neurodegenerative diseases, such as Alzheimer's and Parkinson's; in cancer, in the framework of the Swiss Institute for Experimental Cancer Research (ISREC); and in innovative drug delivery technologies, for instance nanoparticle vaccines.
CombinatoRx, Incorporated today announced that its abstract entitled, "CRx-102 (Prednisolone/Dipyridamole Combination) Enhances Glucocorticoid (GC) Efficacy and Reduces Adverse Effects in OA Therapy: 3-12 Month Results", has been accepted for oral presentation at the American College of Rheumatology (ACR) 2009 Annual Meeting in Philadelphia on October 20, 2009.
Ambit Biosciences Corporation, a recognized global leader in kinase drug discovery and development, announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
People in addiction recovery and their loved ones understand all too well how addiction can damage their relationships. But recovery programs do not always give people the relationship skills needed to address those issues.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kimberly Goergiann Bray, OD 2862 E Cherokee Trail Dr, Terre Haute, IN 47802-5000 Ph: (812) 298-0170 | Dr Kimberly Goergiann Bray, OD 3801 S Us Highway 41 Ste A-1, Terre Haute, IN 47802-4107 Ph: (812) 232-7461 |
News Archive
Merck Serono, a division of Merck KGaA, and EPFL (Ecole Polytechnique Fédérale de Lausanne), one of the two Swiss Federal Institutes of Technology, announced the signing of a research collaboration agreement in the areas of Neuroscience, Oncology and Drug Delivery. Under this agreement, three Merck Serono-endowed Chairs will be created at EPFL: in neurodegenerative diseases, such as Alzheimer's and Parkinson's; in cancer, in the framework of the Swiss Institute for Experimental Cancer Research (ISREC); and in innovative drug delivery technologies, for instance nanoparticle vaccines.
CombinatoRx, Incorporated today announced that its abstract entitled, "CRx-102 (Prednisolone/Dipyridamole Combination) Enhances Glucocorticoid (GC) Efficacy and Reduces Adverse Effects in OA Therapy: 3-12 Month Results", has been accepted for oral presentation at the American College of Rheumatology (ACR) 2009 Annual Meeting in Philadelphia on October 20, 2009.
Ambit Biosciences Corporation, a recognized global leader in kinase drug discovery and development, announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
People in addiction recovery and their loved ones understand all too well how addiction can damage their relationships. But recovery programs do not always give people the relationship skills needed to address those issues.
› Verified 2 days ago
Richard Lee Martin Jr., O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2399 State Road 46 South, Wal-mart Vision Center, Terre Haute, IN 47803 Phone: 812-872-2537 Fax: 812-872-2539 | |
Dr. Steven G Black, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4424 S 7th St, Terre Haute, IN 47801 Phone: 812-299-3937 Fax: 812-299-8670 | |
Dr. Don E Auxier, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4350 S Us Highway 41, Sam's Club, Terre Haute, IN 47802 Phone: 812-238-5532 Fax: 812-238-5681 | |
East Office Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2399 S State Road 46, Walmart Vision Center #4235, Terre Haute, IN 47803 Phone: 812-872-2537 Fax: 812-872-2539 | |
Family First Vision Care Kentucky, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 114 W Honey Creek Pkwy, Terre Haute, IN 47802 Phone: 205-624-2015 | |
Dr. Leighton Allen Harper, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 114 W Honey Creek Pkwy, Terre Haute, IN 47802 Phone: 812-234-6500 |